MissionIR's  Instablog

Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
My blog:
MissionIR Blog
  • AV Therapeutics, Inc. (AVTH) Commences Trading On The OTCQB 0 comments
    Jan 3, 2014 1:49 PM | about stocks: AVTH

    Cancer therapeutics and vaccines developer AV Therapeutics announced that on Dec. 27, its common stock began trading on the OTC Market Group's OTCQB Marketplace under the symbol "AVTH."

    The company has identified and patented Capridine, a chemo therapeutic drug that has demonstrated specific activity against prostate and colon cancer in preclinical models. Capridine is anticipated to be AV Therapeutics' frontline product - specifically in prostate cancer, for which limited chemotherapy treatments currently exist. Counting funding from the National Institutes of Health and the Department of Defense, more than $6 million has been invested in the development of the drug.

    AV Therapeutics plans to enter Phase I trials for Capridine in the second quarter of 2014. These trials will be led by the Prostate Consortium, which is comprised of 16 leading academic medical centers in the United States.

    AV Therapeutics is focused on the business of developing cancer therapeutics and immunotherapeutic vaccines that can be used alone or combined with prevalent treatment modalities like chemotherapy and radiation to treat active disease and prevent metastases and recurrence. The company's immune-therapeutics is based on the capability of certain proprietary reagents to re-educate or reprogram an immune system to target micro-metastases that were previously unidentified. AV Therapeutics plans to clinically develop both approaches for metastatic and early-stage prostate cancer.

    For more information, visit the company's website at avtherapeutics.com

    MissionIR provides investor relations services to publicly traded companies in exchange for compensation. This article may be part of our efforts to widen a client's exposure. To read our full disclaimer, visit http://disclaimer.missionir.com

    Stocks: AVTH
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.